Gorevic Jason N's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 3, 2023
- Accession no.
- 0001415889-23-004099
- Filed
- Mar 3, 2023
- Trade date
- Mar 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 8 derivative transactions. Open-market sales total $209.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorevic Jason NCIK 0001208500 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +22,458 | –F1 | – | 588,922 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −8,262 | $25.36 | −$209,524.32 | 580,660 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +9,104 | –F1 | – | 589,764 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +15,476 | –F4 | – | 605,240 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +3,891 | –F4 | – | 609,131 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +7,648 | –F1 | – | 616,779 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +5,782 | –F4 | – | 622,561 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +2,913 | –F4 | – | 625,474 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −22,458 | $0.00 | $0 | 44,918 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −9,104 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −15,476 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −3,891 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −7,648 | $0.00 | $0 | 7,648 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −5,782 | $0.00 | $0 | 5,782 | Direct | |
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +5,828 | $0.00 | $0 | 5,828 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −2,913 | $0.00 | $0 | 2,915 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F4
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 4 transactions in Table I.